CanadaTeva-Indomethacin capsules (Indomethacin 50 mg), DIN 00337439, lots 100072497, 100072498 and 100072499 sold nationally are affected. They were recalled because the assay may be out of specification; verify if your product is affected, consult your healthcare provider before discontinuing use, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Teva Canada Limited 30 Novopharm Court, Toronto, Ontario M1B 2K9.
How to identify it
Product Name: Teva-Indomethacin; Market Authorization: DIN 00337439; Dosage Form: Capsules; Strength: INDOMETHACIN 50 MG; Lot number: 100072497, 100072498 & 100072499
The hazard
The assay may be out of specification in the affected lots.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)